Why is a new Indian drug not getting any interest in the U.S.?
Indian pharmaceutical stocks are still struggling to find traction in the United States, as the country struggles with a resurgent opioid crisis and its biggest rival, United Kingdom-based Covid-19, continues to surge in the marketplace.In India, Covid and generic versions of other drugs are now available over the counter, as India has emerged as a…